BioMed21 About Us

About Us

The Biomedical Research for the 21st Century (BioMed21) Collaboration initially grew out of a 2015 review publication authored by a diverse group of eminent scientists who recognized the translational limitations of the current paradigm in biomedical research and drug discovery built on animal models, and the need for change. 

 

We are an international team of scientists, policy experts and communication specialists who are passionate about scientific progress and deeply value human and animal lives. We believe that the unprecedented development of New Approach Methodologies (NAMs) such as organs-on-chip, computational methods or bioprinting can put science on a path to eliminating the use of animals in laboratories, while offering researchers new and powerful tools to tackle the major human health challenges of this century.  

 

We articulate this ambitious long-term vision beneficial to animals as well as to patients around attainable policy goals and scientific projects that bring added value to the scientific community in areas as diverse as education, funding and scientific publishing. 

 

Respect, dialogue and inclusion of diverse viewpoints are core values of the BioMed21 Collaboration, and we work in partnership with academic institutions, governments, charities, agencies and the corporate sector.  

Featured collaborations

How we work

Collaborations — We’re building exciting new partnerships around scientific projects with academic, corporate, research funding, and other stakeholders to advance our shared vision.

Funding reviews — We’re supporting open-access publication of independent scientific reviews across a variety of human diseases, with recommendations for new research directions and opportunities utilizing the growing toolbox of 21st century, human-specific tools and technologies.

International workshops — We’re stimulating strategic scientific dialogue on regional and global levels, bringing key stakeholders together to explore and develop consensus recommendations around barriers, opportunities, and priorities for future research funding.

Policy advice — We participate in policy debates about the future of health research through reports and recommendations in the regions where we are active: Europe, Canada, Brazil, India and South Korea.

Team

Helder Constantino
HSI Director,
Research Policy
European Union

LinkedIn

Bianca Marigliani
HSI Senior Strategist, Research & Regulatory Science
Brazil

LinkedIn

Borami Seo
HSI Director, Government Affairs
Korea

LinkedIn

Shaarika Sarasija, PhD
HSI Senior Strategist, Research & Regulatory Science
Canada

LinkedIn

Marta Etynkowski
HSI Digital Specialist, Research & Toxicology
Canada

LinkedIn

Subscribe to our blog!

Enter your email address to receive notifications of new posts by email.